rs56326652

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001852.4(COL9A2):​c.738+10T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0533 in 1,613,950 control chromosomes in the GnomAD database, including 2,581 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.043 ( 217 hom., cov: 32)
Exomes 𝑓: 0.054 ( 2364 hom. )

Consequence

COL9A2
NM_001852.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.267

Publications

3 publications found
Variant links:
Genes affected
COL9A2 (HGNC:2218): (collagen type IX alpha 2 chain) This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. This chain is unusual in that, unlike the other two type IX alpha chains, it contains a covalently attached glycosaminoglycan side chain. Mutations in this gene are associated with multiple epiphyseal dysplasia. [provided by RefSeq, Jul 2008]
COL9A2 Gene-Disease associations (from GenCC):
  • epiphyseal dysplasia, multiple, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Stickler syndrome, type 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • multiple epiphyseal dysplasia due to collagen 9 anomaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive Stickler syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Stickler syndrome
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 1-40310254-A-G is Benign according to our data. Variant chr1-40310254-A-G is described in ClinVar as [Benign]. Clinvar id is 258394.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0631 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL9A2NM_001852.4 linkc.738+10T>C intron_variant Intron 14 of 31 ENST00000372748.8 NP_001843.1 Q14055

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL9A2ENST00000372748.8 linkc.738+10T>C intron_variant Intron 14 of 31 1 NM_001852.4 ENSP00000361834.3 Q14055
COL9A2ENST00000482722.5 linkn.1041+10T>C intron_variant Intron 13 of 30 1
COL9A2ENST00000488463.6 linkn.789+10T>C intron_variant Intron 13 of 13 5
COL9A2ENST00000417105.6 linkc.*36T>C downstream_gene_variant 5 ENSP00000388493.2 H0Y409

Frequencies

GnomAD3 genomes
AF:
0.0426
AC:
6481
AN:
152114
Hom.:
217
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0101
Gnomad AMI
AF:
0.00659
Gnomad AMR
AF:
0.0290
Gnomad ASJ
AF:
0.0470
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0298
Gnomad FIN
AF:
0.0772
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0647
Gnomad OTH
AF:
0.0392
GnomAD2 exomes
AF:
0.0444
AC:
11170
AN:
251408
AF XY:
0.0458
show subpopulations
Gnomad AFR exome
AF:
0.0100
Gnomad AMR exome
AF:
0.0213
Gnomad ASJ exome
AF:
0.0442
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0710
Gnomad NFE exome
AF:
0.0625
Gnomad OTH exome
AF:
0.0459
GnomAD4 exome
AF:
0.0544
AC:
79587
AN:
1461718
Hom.:
2364
Cov.:
34
AF XY:
0.0542
AC XY:
39403
AN XY:
727172
show subpopulations
African (AFR)
AF:
0.00848
AC:
284
AN:
33478
American (AMR)
AF:
0.0227
AC:
1017
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0468
AC:
1223
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0298
AC:
2571
AN:
86258
European-Finnish (FIN)
AF:
0.0660
AC:
3522
AN:
53398
Middle Eastern (MID)
AF:
0.0293
AC:
169
AN:
5768
European-Non Finnish (NFE)
AF:
0.0611
AC:
67939
AN:
1111864
Other (OTH)
AF:
0.0474
AC:
2861
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
4448
8895
13343
17790
22238
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2420
4840
7260
9680
12100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0426
AC:
6480
AN:
152232
Hom.:
217
Cov.:
32
AF XY:
0.0429
AC XY:
3191
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.0100
AC:
417
AN:
41524
American (AMR)
AF:
0.0290
AC:
443
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0470
AC:
163
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5188
South Asian (SAS)
AF:
0.0303
AC:
146
AN:
4826
European-Finnish (FIN)
AF:
0.0772
AC:
818
AN:
10602
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0647
AC:
4401
AN:
68004
Other (OTH)
AF:
0.0388
AC:
82
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
328
656
985
1313
1641
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0486
Hom.:
71
Bravo
AF:
0.0365
Asia WGS
AF:
0.0130
AC:
46
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 17, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epiphyseal dysplasia, multiple, 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Connective tissue disorder Benign:1
May 12, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.4
DANN
Benign
0.64
PhyloP100
-0.27
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56326652; hg19: chr1-40775926; API